UK utility weights for the EORTC QLU-C10D

被引:46
|
作者
Norman, Richard [1 ]
Mercieca-Bebber, Rebecca [2 ,3 ]
Rowen, Donna [4 ]
Brazier, John E. [4 ]
Cella, David [5 ]
Pickard, A. Simon [6 ]
Street, Deborah J. [7 ]
Viney, Rosalie [8 ]
Revicki, Dennis [2 ]
King, Madeleine T. [2 ]
机构
[1] Curtin Univ, Sch Publ Hlth, Perth, WA, Australia
[2] Univ Sydney, Fac Sci, Sch Psychol, Sydney, NSW, Australia
[3] Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW, Australia
[4] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England
[5] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[6] Univ Illinois, Coll Pharm, Dept Pharm Syst Outcomes & Policy, Chicago, IL USA
[7] Univ Technol Sydney, Cl1ERE, Sydney, NSW, Australia
[8] Patient Ctr Res, Bethesda, MD USA
基金
英国医学研究理事会;
关键词
cancer; discrete choice experiment; health state valuation; utility; DISCRETE-CHOICE EXPERIMENT; PREFERENCE-BASED MEASURE; HEALTH STATES; INSTRUMENT; VALUATION; QLQ-C30; IMPACT; VALUES; QALYS;
D O I
10.1002/hec.3950
中图分类号
F [经济];
学科分类号
02 ;
摘要
The EORTC QLU-C10D is a new multi-attribute utility instrument derived from the widely used cancer-specific quality of life questionnaire, EORTC QLQ-C30. It contains 10 dimensions (physical functioning, role functioning, social functioning, emotional functioning, pain, fatigue, sleep, appetite, nausea, bowel problems), each with four levels. The aim of this study was to provide U.K. general population utility weights for the QLU-C10D. A U.K. online panel was quota-sampled to align the sample to the general population proportions of sex and age (>= 18 years). The online valuation survey included a discrete choice experiment (DCE). Each participant was asked to complete 16 choice-pairs, each comprising two QLU-C10D health states plus duration. DCE data were analysed using conditional logistic regression to generate utility weights. Data from 2,187 respondents who completed at least one choice set were included in the DCE analysis. The final U.K. QLU-C10D utility weights comprised decrements for each level of each health dimension. For nine of the 10 dimensions (all except appetite), the expected monotonic pattern was observed across levels: Utility decreased as severity increased. For the final model, consistent monotonicity was achieved by merging inconsistent adjacent levels for appetite. The largest utility decrements were associated with physical functioning and pain. The worst possible health state (the worst level of each dimension) is -0.083, which is considered slightly worse than being dead. The U.K.-specific utility weights will enable cost-utility analysis (CUA) for the economic evaluation of new oncology therapies and technologies in the United Kingdom, where CUA is commonly used to inform resource allocation.
引用
收藏
页码:1385 / 1401
页数:17
相关论文
共 50 条
  • [21] QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30
    M. T. King
    D. S. J. Costa
    N. K. Aaronson
    J. E. Brazier
    D. F. Cella
    P. M. Fayers
    P. Grimison
    M. Janda
    G. Kemmler
    R. Norman
    A. S. Pickard
    D. Rowen
    G. Velikova
    T. A. Young
    R. Viney
    Quality of Life Research, 2016, 25 : 625 - 636
  • [22] Comparison of EQ-5D-5L and EORTC QLU-C10D utilities in gastric cancer patients
    Pan, Chen-Wei
    He, Jun-Yi
    Zhu, Yan-Bo
    Zhao, Chun-Hua
    Luo, Nan
    Wang, Pei
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2023, 24 (06) : 885 - 893
  • [23] A comparison of measurement properties between EORTC QLU-C10D and FACT-8D in patients with hematological malignances
    Cao, Yiyin
    Li, Haofei
    Cheng, Ling Jie
    King, Madeleine T.
    Kemmler, Georg
    Cella, David
    Yu, Hongjuan
    Huang, Weidong
    Luo, Nan
    HEALTH ECONOMICS REVIEW, 2024, 14 (01):
  • [24] Using a discrete choice experiment to value the QLU-C10D: feasibility and sensitivity to presentation format
    R. Norman
    R. Viney
    N. K. Aaronson
    J. E. Brazier
    D. Cella
    D. S. J. Costa
    P. M. Fayers
    G. Kemmler
    S. Peacock
    A. S. Pickard
    D. Rowen
    D. J. Street
    G. Velikova
    T. A. Young
    M. T. King
    Quality of Life Research, 2016, 25 : 637 - 649
  • [25] Comparison of EQ-5D-5L and EORTC QLU-C10D utilities in gastric cancer patients
    Chen-Wei Pan
    Jun-Yi He
    Yan-Bo Zhu
    Chun-Hua Zhao
    Nan Luo
    Pei Wang
    The European Journal of Health Economics, 2023, 24 : 885 - 893
  • [26] French Value-Set of the QLU-C10D, a Cancer-Specific Utility Measure Derived from the QLQ-C30
    Nerich, Virginie
    Gamper, Eva Maria
    Norman, Richard
    King, Madeleine
    Holzner, Bernhard
    Viney, Rosalie
    Kemmler, Georg
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2021, 19 (02) : 191 - 202
  • [27] The EORTC QLU-C10D was more efficient in detecting clinical known group differences in myelodysplastic syndromes than the EQ-5D-3L
    Gamper, Eva M.
    Cottone, Francesco
    Sommer, Kathrin
    Norman, Richard
    King, Madeleine
    Breccia, Massimo
    Caocci, Giovanni
    Patriarca, Andrea
    Palumbo, Giuseppe A.
    Stauder, Reinhard
    Niscola, Pasquale
    Platzbecker, Uwe
    Caers, Jo
    Vignetti, Marco
    Efficace, Fabio
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2021, 137 : 31 - 44
  • [28] Estimation of an EORTC QLU-C10 Value Set for Spain Using a Discrete Choice Experiment
    Finch, Aureliano Paolo
    Gamper, Eva
    Norman, Richard
    Viney, Rosalie
    Holzner, Bernhard
    King, Madeleine
    Kemmler, Georg
    PHARMACOECONOMICS, 2021, 39 (09) : 1085 - 1098
  • [29] Valuation of the EORTC Quality of Life Utility Core 10 Dimensions (QLU-C10D) in a Multi-ethnic Asian Setting: How Does Having Cancer Matter?
    Gandhi, Mihir
    Kanesvaran, Ravindran
    Rashid, Mohamad Farid Bin Harunal
    Chong, Dawn Qingqing
    Chay, Wen-Yee
    Tan, Rachel Lee-Yin
    Norman, Richard
    King, Madeleine T.
    Luo, Nan
    PHARMACOECONOMICS, 2024, 42 (12) : 1413 - 1425
  • [30] Cancer-specific health utilities: Evaluation of the clinical validity and measurement properties of the EORTC QLU-C10D in various cancer populations
    Pilz, Micha Johannes
    Seyringer, Simone
    King, Madeleine
    Bottomley, Andrew
    Norman, Richard
    Schlosser, Lisa
    Hell, Tobias
    Gamper, Eva Maria
    MEDICAL DECISION MAKING, 2024, 44 (02) : NP157 - NP158